A New Treatment For Alzheimer’s Improves How Drugs Reach The Brain

<a href="https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447" rel="noopener ugc nofollow" target="_blank">Alzheimer’s Disease</a> is a neurodegenerative disorder that, in advanced stages, devastates memory and cognitive functions. Despite much research over many decades, it remains clinically challenging to manage, with different treatment strategies showing mixed and limited results. Alzheimer’s Disease is characterized by the accumulation of amyloid-beta plaques and neurofibrillary tangles — which consist of abnormally elevated levels of a protein called tau — in the brain. Alzheimer’s affects millions worldwide, with numbers expected to continue rising as populations age. <a href="https://www.cdc.gov/aging/alzheimers-disease-dementia/about-alzheimers.html#:~:text=In%202023%2C%20an%20estimated%206.7,or%20older%20had%20Alzheimer's%20disease.&text=1-,This%20number%20is%20projected%20to%20nearly,14%20million%20people%20by%202060." rel="noopener ugc nofollow" target="_blank">According to the Center for Disease Control and Prevention</a>, there were an estimated 6.7 million Americans aged 65 years or older who had Alzheimer’s Disease in 2023. They project this number to triple to about 14 million people by 2060. <a href="https://gabriel-silva.medium.com/a-new-treatment-for-alzheimers-improves-how-drugs-reach-the-brain-4dbb256837fc">Read More</a>